Clinical Trials Update: July 2, 2009

• Rhinitis, Allergic, Perennial
• Depression
• Diabetic Neuropathy
• ADHD (Attention Deficit Hyperactivity Disorder)
• Menopause and Osteoporosis Prevention
• Healthy Volunteers (Ages 18-65)

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch and ClinicalConnection.com:

Rhinitis, Allergic, Perennial

If your child (boys aged five to eight and girls aged five to seven) has had allergy symptoms for at least one year, he or she may qualify for this study.

The research site is in Metairie, La.

More information

Please see http://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=804.

-----

Depression

If you are an adult with depression, you may qualify for this study.

The research site is in Washington, D.C.

More information

Please seehttp://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=164 .

-----

Diabetic Neuropathy

If you have diabetes and have complications of painful neuropathy (nerve damage), you may qualify for this study.

The research site is in St. Petersburg, Fla.

More information

Please seehttp://www.centerwatch.com/clinical-trials/listings/studylist.aspx?CatID=253.

-----

ADHD (Attention Deficit Hyperactivity Disorder)

This study will include people aged 18 to 55 with symptoms or a diagnosis of ADHD. Participants may receive study medication and study related medical care at no cost, and will be compensated for time and travel.

The research site is in Libertyville, Ill.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/adhd.aspx.

-----

Menopause and Osteoporosis Prevention

This study will evaluate the safety and efficacy of an investigational drug designed to prevent postmenopausal osteoporosis and treat menopausal symptoms while ensuring endometrial (uterine lining) safety.

The research site is in New London, CT.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/menopause.aspx.

-----

Healthy Volunteers (Ages 18-65)

This study will evaluate an investigational PET imaging agent. If you qualify and complete phase one, you may receive up to $810 and be eligible for a second phase of the trial.

The research site is in Baltimore, Md.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/healthy_volunteers.aspx.

-----

Copyright 2009 CenterWatch and ClinicalConnection.com. All rights reserved.